These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8385301)

  • 1. Rifampicin-protamine protocol applied for prevention of central catheter sepsis in haemodialysis.
    Montagnac R; Schillinger F
    Nephrol Dial Transplant; 1993; 8(3):289-90. PubMed ID: 8385301
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of bacteremia from central venous catheters in hemodialysis: value of application of a mixture of rifampicin and protamine at the insertion site].
    Montagnac R; Schillinger F; Eloy C
    Nephrologie; 2003; 24(4):159-65. PubMed ID: 12891830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Apropos of rifampicin-protamine protocol used in the prevention of infections from central venous catheters in hemodialysis].
    Montagnac R; Schillinger F
    Nephrologie; 1994; 15(5):361. PubMed ID: 7816167
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia.
    Lorente L; Lecuona M; Ramos MJ; Jiménez A; Mora ML; Sierra A
    Clin Infect Dis; 2008 Nov; 47(9):1171-5. PubMed ID: 18808356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rifampicin-protamine protocol applied to central venous catheters during hemodialysis. L'Equipe Infirmière].
    Montagnac R; Schillinger F
    Nephrologie; 1994; 15(2):163-4. PubMed ID: 8047205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rifampicin protocol--protamine administered by central venous catheters in hemodialysis].
    Montagnac R; Schillinger F
    Nephrologie; 1992; 13(2):101-2. PubMed ID: 1608498
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rifampicin-protamine sulfate solution in dialysis patients].
    Lecame M; Legras S; Ficheux M; Henri P; Ryckelynck JP; Lobbedez T
    Nephrol Ther; 2008 Oct; 4(5):330-4. PubMed ID: 18455487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catheters: traveling the bacterial highway.
    Banerjee S
    Nephrol News Issues; 2008 Oct; 22(11):39, 46. PubMed ID: 19048694
    [No Abstract]   [Full Text] [Related]  

  • 9. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
    Fraenkel D; Rickard C; Thomas P; Faoagali J; George N; Ware R
    Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of central venous catheter: prevention of thrombosis and bacteremia].
    Lomonte C; Basile C
    G Ital Nefrol; 2009; 26(1):73-80. PubMed ID: 19255966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is peripheral and/or catheter blood necessary for performing haemoculture in haemodialysis patients whose central venous catheter presents bacteraemia?
    Betancor-Jiménez JF; Alonso-Almán F; Parodis-López Y; Quintana-Viñau B; González-Martinez S; García-Laverick C; Pérez-Borges P; Rodríguez-Pérez JC
    Nefrologia; 2012; 32(1):118-20. PubMed ID: 22294012
    [No Abstract]   [Full Text] [Related]  

  • 12. Strategies for preventing catheter-related bloodstream infections: the role of new technologies.
    Lubelchek RJ; Weinstein RA
    Crit Care Med; 2006 Mar; 34(3):905-7. PubMed ID: 16505678
    [No Abstract]   [Full Text] [Related]  

  • 13. Central venous catheter care.
    Dart CR; Cooke RP
    Br J Hosp Med; 1995 Feb 1-14; 53(3):113-4. PubMed ID: 7728312
    [No Abstract]   [Full Text] [Related]  

  • 14. An infected right atrial thrombus--a new complication of haemodialysis associated subclavian vein catheterisation.
    Korzets A; Katz S; Chagnac A; Katz M; Gafter U; Zevin D; Levi J
    Nephrol Dial Transplant; 1994; 9(11):1652-4. PubMed ID: 7870359
    [No Abstract]   [Full Text] [Related]  

  • 15. A prospective study of central venous hemodialysis catheter colonization and peripheral bacteremia.
    Dittmer ID; Sharp D; McNulty CA; Williams AJ; Banks RA
    Clin Nephrol; 1999 Jan; 51(1):34-9. PubMed ID: 9988144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central venous catheter-associated Leifsonia aquatica bacteremia in a hemodialysis-dependent patient.
    Sulpher J; Desjardins M; Lee BC
    Diagn Microbiol Infect Dis; 2008 May; 61(1):64-6. PubMed ID: 18243628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of recurrent central venous catheter infections with a novel flush solution in a patient on long-term hemodialysis.
    Sheth KJ; Henrickson KJ
    Pediatr Nephrol; 1993 Aug; 7(4):506. PubMed ID: 8398668
    [No Abstract]   [Full Text] [Related]  

  • 18. Relapsing bacteraemia due to Micrococcus luteus in a haemodialysis patient with a Perm-Cath catheter.
    Peces R; Gago E; Tejada F; Laures AS; Alvarez-Grande J
    Nephrol Dial Transplant; 1997 Nov; 12(11):2428-9. PubMed ID: 9394339
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of an antibiotic lock for the prevention of bacteremia recurrence from central catheters in chronic hemodialysis].
    Fourcade J; Mallaval FO; Raffenot D; Mercier D; Maret J; Morel B
    Nephrologie; 2001; 22(8):457-8. PubMed ID: 11811009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials.
    Falagas ME; Fragoulis K; Bliziotis IA; Chatzinikolaou I
    J Antimicrob Chemother; 2007 Mar; 59(3):359-69. PubMed ID: 17255143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.